Company Profiles

CEOLIVE Profiles Up and Coming Innovative Companies

How One Cleantech Stock is Fighting Pollution on the High Seas
31 Jul
2016
Written by Mike Elliott

How One Cleantech Stock is Fighting Pollution on the High Seas »

Pacific Green Technologies, ticker PGTK, has developed a portfolio of Emissions Control Technologies for use in both power plant and marine applications.

Read more...
$VUZI | Vuzix Adds More Companies to VIP Program for M300 Smart Glasses
28 Jul
2016
Written by Mike Elliott

$VUZI | Vuzix Adds More Companies to VIP Program for M300 Smart Glasses »

Vuzix announced recently that they have added APX labs as well as Ubimax as the newest members to their Industrial Partner (VIP) program. APX labs has a host of leading companies as customers including boeing, GE, Tesla, Johnson and Johnson, Exxon Mobile and many others. Ubimax is a leading supplier for industrial wearable computing solutions.

Read more...
$NNDM | Nano Inks, Bioprinting & the Future of 3D Printers
26 Jul
2016
Written by Mike Elliott

$NNDM | Nano Inks, Bioprinting & the Future of 3D Printers »

Technology innovator, Nano Dimension, an emerging leader in 3D printing hardware, software and specialized inks lets CEOLIVE talk with their Head of Chemistry, Hila Elimelech, PhD.

Read more...
$VUZI | Vuzix Corp.’s Highly Anticipated AR Smart Glasses Begin Shipping
14 Jul
2016
Written by Mike Elliott

$VUZI | Vuzix Corp.’s Highly Anticipated AR Smart Glasses Begin Shipping »

As interest in augmented and virtual reality continues to grow, Vuzix Corp. (VUZI) has begun shipments of its newest innovation, the M300 Smart Glasses for hands free mobile computing.

Read more...
$PYDS | Payment Data Targets Mobile Payments with Aggressive Growth Strategy
7 Jul
2016
Written by Mike Elliott

$PYDS | Payment Data Targets Mobile Payments with Aggressive Growth Strategy »

In this episode of the CEOLIVE Investor Profile Series we interview COO, Louis Hoch and SVP of Corporate Development from Payment Data Systems, ticker PYDS.

Read more...
$CTXR | Potential $500M Product Entering Phase 3 Trials
20 Jun
2016
Written by Mike Elliott

$CTXR | Potential $500M Product Entering Phase 3 Trials »

Citius is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for healthcare markets where there are unmet needs using innovative, patented or proprietary formulations of pharmaceutical products.

Read more...

Login

Lost your password?